ShadowBuys

Bristol-Myers Squibb Company (BMY)

Healthcare · Drug Manufacturers - General

26 members of Congress have disclosed 82 trades in Bristol-Myers Squibb Company (BMY) since 2014: 32 buys and 50 sales. The most recent was disclosed on Jul 21, 2026. 3 trades were made by members of a committee that oversees Bristol-Myers Squibb Company's industry.

Trades disclosed
82
Members trading
26
Buys / sells
32 / 50
Reported value
$949K–$3.1M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow BMY

What else is happening at BMY

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

No matching research items have been collected yet. Coverage is growing; an empty result does not mean there has been no activity.

Committee overlaps

Trades by members of a committee that oversees Bristol-Myers Squibb Company's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded BMY

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.